At 2.20 pm, the scrip was trading 2.78 per cent higher at Rs 646.10 on the BSE as against a rise of 1.70 per cent in the S&P BSE Sensex.
"The company has received and signed Letter of Intent (LoI) amounting to Rs 1,100 crore from one of the top 10 multinational life sciences company for supplying life sciences related speciality chemicals," Anupam Rasayan said in an exchange filing. READ HERE
The company will be providing multiple products to the multinational firm for the next five years, it added.
Anupam Rasayan has over 53 domestic and international customers, including 17 multinational companies.
Commenting on the order win, Anand Desai, Managing Director at the firm said, "Securing order from a leading multinational company in the light of prevailing global uncertainty is a testament to our research and development process, latest technology, infrastructure and quality of our existing products."
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)